Coeptis Therapeutics Holdings, Inc.

The momentum for this stock is not very good. Coeptis Therapeutics Holdings, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Coeptis Therapeutics Holdings, Inc..
Log in to see more information.
COEP Fundamental Data by TradingView

News

Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering

PR Newswire Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering PR Newswire WEXFORD, Pa., June 20, 2024 Bolsters...\n more…

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest

Zolmax Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP - Get Free Report) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 546,800 shares, an...\n more…

Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting

PR Newswire Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit...\n more…

COEP Stock Earnings: Coeptis Therapeutics Reported Results for Q1 2024
COEP Stock Earnings: Coeptis Therapeutics Reported Results for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nCoeptis Therapeutics just reported results for the first quarter of 2024.\nThe post COEP Stock Earnings: Coeptis Therapeutics Reported...\n more…

Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024

PR Newswire Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024 Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024...\n more…

Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting

PR Newswire Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting Coeptis Therapeutics Announces Poster Data Presentation at American...\n more…